How to Test for ApoB: A Simple Blood Test for Heart Health

Testing for apolipoprotein B (apoB) requires nothing more than a standard blood draw, the same kind used for a routine cholesterol panel. A lab technician draws a small sample from a vein, usually in your arm, and the sample is analyzed using an automated immunoassay that measures the concentration of apoB protein in your blood. The test is widely available at commercial labs and most hospital laboratories, though it is not yet included in a default lipid panel in the United States. You typically need to ask your doctor for it specifically, or your doctor may order it when a standard cholesterol check leaves questions unanswered.

What Happens During the Test

The blood draw itself is identical to what you experience during any routine lab work. A vial of blood is collected and sent to the lab, where the serum is separated out and analyzed. The most common method labs use is called an immunoturbidimetric assay, which works by mixing your serum with antibodies that bind specifically to apoB protein. When the antibodies latch onto apoB, the solution becomes cloudy in proportion to how much apoB is present, and a machine reads that cloudiness to produce a number in milligrams per deciliter (mg/dL).¹ Results typically come back within a day or two, alongside any other blood work your doctor ordered.

One practical question people have is whether you need to fast before the test. Traditional lipid panels require a 12-hour fast because eating changes your triglyceride and LDL-cholesterol numbers. ApoB levels, however, are relatively stable after eating. A large study from the Women’s Health Study found that while LDL cholesterol and non-HDL cholesterol were somewhat less predictive of cardiovascular events when measured in a nonfasting state, apoB concentrations changed only modestly with food intake.² That said, many doctors still order apoB alongside a standard lipid panel that does require fasting, so in practice you may be told to fast anyway. If your doctor is ordering apoB on its own, a nonfasting draw is generally fine.

Why ApoB Tells You Something Cholesterol Numbers Miss

Every particle in your blood that can deposit cholesterol into your artery walls carries exactly one molecule of apoB on its surface. That includes LDL particles, VLDL particles, intermediate-density lipoproteins, and lipoprotein(a). Because each dangerous particle carries one apoB molecule, measuring apoB gives you a direct count of how many atherogenic particles are circulating, rather than how much cholesterol those particles happen to be carrying.³

This distinction matters because LDL particles are not all the same size, and they do not all carry the same amount of cholesterol. A person whose LDL particles are small and cholesterol-depleted can have a normal-looking LDL-cholesterol number while actually having a dangerously high number of LDL particles. Their standard cholesterol test looks reassuring, but their artery walls are seeing a heavy load of particles trying to burrow in. The reverse also happens: someone with large, cholesterol-rich LDL particles may have an elevated LDL-cholesterol reading but relatively few particles. ApoB resolves the ambiguity by counting the particles directly.

A head-to-head comparison published in 2025 found that apoB outperformed LDL cholesterol as a predictor of atherosclerotic cardiovascular disease in every study examined, and was a more accurate marker than non-HDL cholesterol in most comparisons as well.⁴ A review in Current Cardiology Reports put it more bluntly: when apoB and non-HDL cholesterol disagree, apoB is the more accurate gauge, especially in people with moderately elevated triglycerides, diabetes, obesity, metabolic syndrome, or very low LDL cholesterol.⁵

When ApoB and LDL Cholesterol Disagree

Researchers call this “discordance,” and it is more common than most people realize. Your LDL cholesterol might read 100 mg/dL, which looks perfectly fine by conventional guidelines, while your apoB is elevated because you have a large number of small, cholesterol-poor LDL particles. Data from the CARDIA study, which tracked young adults over 25 years, found that people with high apoB but low LDL cholesterol had roughly 55% higher odds of developing coronary artery calcification compared to those whose numbers agreed and were both low.⁶ These were young adults, not elderly patients with obvious risk factors, which makes the finding particularly striking.

A 2024 study in the Journal of the American College of Cardiology examined what happens when apoB is higher than LDL cholesterol would predict. Researchers defined “excess apoB” as the amount of apoB above what you would expect from someone’s LDL-cholesterol level alone. They found a dose-dependent relationship: the more excess apoB, the higher the risk of heart attack and atherosclerotic cardiovascular disease, in both women and men. Women in the highest excess-apoB category had about 75% greater risk of cardiovascular disease than those in the lowest category. Results held across the entire range of LDL-cholesterol values.⁷

The practical takeaway is that a normal LDL-cholesterol number does not guarantee your particle count is safe. If you have conditions that tend to produce small, dense LDL particles, your cholesterol reading can be misleading in a way that matters for your long-term health.

Who Should Get Tested

U.S., European, and Canadian guidelines all endorse measuring apoB for cardiovascular risk assessment, though they differ somewhat on exactly when to order it. The consensus from the National Lipid Association recommends apoB measurement particularly in people with elevated triglycerides, type 2 diabetes, visceral obesity, insulin resistance or metabolic syndrome, low HDL cholesterol, or very low LDL cholesterol.⁸ These are the situations where standard cholesterol numbers are most likely to be misleading.

People with type 2 diabetes deserve special mention. In one study of diabetic patients, apoB levels climbed steadily with the number of metabolic syndrome features a person had, and this relationship held even after adjusting for LDL cholesterol, age, and sex. Triglycerides and systolic blood pressure were the metabolic syndrome components most strongly linked to higher apoB.⁹ A separate study confirmed the pattern: as BMI increased in type 2 diabetic patients, apoB levels rose in a stepwise fashion, from about 1.02 g/L in normal-weight individuals to 1.14 g/L in those classified as obese.¹⁰

Even if you do not fall into one of these higher-risk categories, some clinicians argue that everyone should have an apoB measurement at least once, simply because the discordance problem can affect apparently healthy people. The CARDIA data mentioned earlier involved young, generally healthy adults who would not have been flagged by conventional screening.

Understanding Your Results

When your lab report comes back, you will see your apoB level expressed in mg/dL. The general population averages vary by age and sex, but as a rough guide, a level below about 90 mg/dL is considered desirable for someone at average risk. For people at higher cardiovascular risk, guidelines generally suggest targeting below 80 mg/dL, and for those at very high risk, below 65 mg/dL. A review in Circulation synthesized guideline recommendations and proposed evidence-based apoB thresholds to complement existing LDL-cholesterol targets in clinical practice.¹¹

One thing to keep in mind is that these thresholds are not one-size-fits-all. Your doctor will interpret your apoB level in the context of your overall risk profile, including your age, blood pressure, smoking status, family history, and whether you are already on cholesterol-lowering medication. ApoB is a valuable piece of the puzzle, not a standalone verdict.

Lab-to-lab variation is worth knowing about, though it is not large enough to worry over. Researchers have studied the biological variation of apoB in a large European population and found that individual fluctuations from day to day are relatively small, meaning a single measurement is generally reliable for clinical decisions.¹² There were some differences between men and women, and between premenopausal and postmenopausal women, but overall the test performs consistently enough to guide treatment.

How ApoB Connects to Artery Disease

The reason clinicians care about apoB is not abstract. The protein sits at the center of how atherosclerosis actually starts. The initiating event in plaque formation is the trapping of apoB-containing lipoproteins beneath the inner lining of your arteries. Once these particles get stuck in the artery wall, they trigger a chain of inflammatory responses involving immune cells that ultimately build up into the plaques that narrow arteries and cause heart attacks.¹³

The trapping happens because apoB on the surface of these particles binds to molecules called proteoglycans embedded in the artery wall. Not all apoB-containing particles bind equally well. Small, dense LDL particles have the highest affinity for these binding sites, while larger VLDL particles bind less readily, likely because the apoB protein on VLDL is less exposed.¹⁴ As inflammation develops in the artery wall, the local environment becomes more acidic, which actually strengthens the binding and accelerates the process.¹⁵ This is why the total number of apoB-containing particles circulating in your blood matters so much: more particles means more opportunities for retention and more fuel for plaque growth.

What You Can Do About a High ApoB

If your apoB comes back elevated, the response depends on how high it is and your overall risk. Lifestyle changes are the first line for most people. A population-based study found that dietary patterns high in saturated fat and refined carbohydrates were associated with higher apoB levels, while diets rich in fiber, minerals, vitamins, and polyunsaturated fats were linked to the lowest apoB.¹⁶ In practical terms, that means shifting toward more vegetables, fruits, whole grains, nuts, and fish, while cutting back on processed foods, added sugars, and saturated fat sources.

Physical activity and weight loss also help. A study of middle-aged men who completed a one-year program combining personalized dietary counseling with increased physical activity found significant improvements in LDL apoB concentrations. The intervention was designed to produce a modest daily calorie deficit, and the metabolic improvements tracked with changes in a growth-factor protein involved in fat metabolism.¹⁷

When lifestyle changes are not enough, medications come into play. Statins are the most commonly prescribed drugs for lowering apoB, and they work by reducing the liver’s production of cholesterol, which in turn reduces the number of LDL particles the liver secretes into the bloodstream. Ezetimibe, which blocks cholesterol absorption in the gut, can be added for further reduction. For people who need aggressive lowering, PCSK9 inhibitors, a newer class of injectable medications, can produce dramatic drops in both LDL cholesterol and apoB by helping the liver clear more LDL particles from the blood. Your doctor can use apoB measurements to gauge whether your treatment is actually bringing particle numbers down to target, not just lowering the cholesterol cargo on each particle.

Is the Test Worth the Cost

ApoB testing is inexpensive. The test itself typically runs between $10 and $30 at commercial labs when added to a lipid panel, and many insurance plans cover it when ordered for a clinical indication. A cost-effectiveness analysis published in JAMA in 2025 modeled what would happen if doctors used apoB goals instead of non-HDL cholesterol goals to guide preventive treatment. The study found that using an apoB-based strategy would gain about 1,324 additional quality-adjusted life years at a cost of roughly $30,300 per quality-adjusted life year gained, well within the range considered cost-effective. The cost of the apoB test itself was marginal; the higher total costs came from people living longer and staying on preventive treatment for more years.¹⁸

If your doctor is reluctant to order the test, it helps to know that the National Lipid Association, the European Atherosclerosis Society, and the Canadian Cardiovascular Society all include apoB in their recommendations. You can ask specifically for it, and if cost is a concern, some direct-to-consumer lab services offer apoB testing that you can order and pay for yourself without a prescription.

ApoB in Children and Young Adults

Most of the clinical evidence for apoB comes from adult populations, but there is growing interest in measuring it earlier. The Cardiovascular Risk in Young Finns study tracked children and adolescents over decades and found that apoB levels measured between ages 12 and 18 predicted thickening of the carotid artery wall and impaired blood vessel function in adulthood. The ratio of apoB to apoA-I measured in adolescence was actually a better predictor of future artery thickening than the traditional LDL-to-HDL cholesterol ratio.¹⁹

That said, a systematic review and meta-analysis concluded that while apoB levels do track consistently from childhood into adulthood, the evidence does not yet show that apoB outperforms LDL cholesterol for pediatric screening purposes. The reviewers noted that more comprehensive data are needed before recommending routine apoB testing in children.²⁰ For now, pediatric apoB testing is most useful in families with a known genetic lipid disorder, such as familial hypercholesterolemia.

Genetic Conditions That Raise ApoB

Speaking of inherited disorders, there is a condition called familial defective apolipoprotein B-100 that is worth knowing about if you have a family history of very high cholesterol. In this disorder, a single mutation in the apoB gene changes the shape of the protein enough that LDL particles cannot bind properly to the receptors in the liver that normally clear them from the blood. The result is a traffic jam: LDL particles pile up in the bloodstream, and cholesterol levels climb to moderate or severe levels.²¹

This condition is often clinically indistinguishable from familial hypercholesterolemia caused by LDL receptor mutations, and it responds to the same treatments. If you have persistently high LDL cholesterol despite a healthy lifestyle, especially if it runs in your family, genetic testing can distinguish between the two. ApoB levels in affected individuals are typically elevated, but the key diagnostic step is genetic testing rather than the apoB blood test alone.

The Two Flavors of ApoB

Your body actually makes two forms of apolipoprotein B. The liver produces apoB-100, which is the large version found on LDL, VLDL, and other atherogenic particles. The intestine produces apoB-48, a truncated version that rides on particles called chylomicrons, which carry dietary fat from your gut into the bloodstream after a meal. ApoB-48 represents the first 48% of the full apoB-100 protein sequence; the two forms share identical amino acid sequences over that stretch.²²

When your doctor orders an “apoB” test, the result overwhelmingly reflects apoB-100, because chylomicrons carrying apoB-48 are normally cleared from the blood within hours of eating. In a fasting blood sample, apoB-48 contributes negligibly to the total. Specialized research assays can measure apoB-48 separately, but these are used primarily in metabolic studies, not routine clinical care.²³ You do not need to worry about which form your lab is measuring; the standard clinical test gives you the number that matters for heart disease risk.